Are Cladribine and Rituximab Enough for the Treatment of Relapsed Hairy Cell Leukemia?
<p><strong></strong><strong>Introduction:</strong> Hairy cell leukemia is a rare B-cell lymph proliferation with long-term survivals, in general. Although therapeutic possibilities have progressed over time, many patients have recurrences and the disease can become resi...
Saved in:
Main Author: | Romeo-Gabriel Mihaila (Author) |
---|---|
Format: | Book |
Published: |
International Journal of Immunotherapy and Cancer Research - Peertechz Publications,
2015-08-14.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetics of hairy cell leukemia
by: Jorge J. Nieva
Published: (2011) -
Genetics of hairy cell leukemia
by: Jorge J. Nieva
Published: (2011) -
Cost-effectiveness of cladribine tablets and dimethyl fumarate in the treatment of relapsing remitting multiple sclerosis in Spain
by: Ricardo Ginestal, et al.
Published: (2023) -
BRAF mutation in hairy cell leukemia
by: Ahmad Ahmadzadeh, et al.
Published: (2014) -
Hairy cell leukemia: An unusual morphology
by: Sharma Anjali, et al.
Published: (2010)